What is Cryogenx?
Cryogenx is at the forefront of developing portable body cooling technology engineered to combat heatstroke by rapidly reducing core body temperature. Their innovative CGX1 device, a backpack-portable unit that functions akin to an ice bath, offers immediate accessibility in diverse high-risk environments. The company strategically targets sectors such as construction, military operations, civil defense, first responder services, and professional sports – industries where the threat of heat-related illnesses is a persistent concern. With the escalating impact of climate change intensifying heat exposure risks, Cryogenx is positioned to provide a crucial public health solution.
How much funding has Cryogenx raised?
Cryogenx has raised a total of $1M across 1 funding round:
Other Financing Round
$1M
Other Financing Round (2024): $1M with participation from The British Design Fund
Key Investors in Cryogenx
The British Design Fund
The British Design Fund is dedicated to investing in purpose-led British product businesses to foster enterprise and innovation in the UK. They provide financial support alongside invaluable mentoring and networking, helping entrepreneurs to scale their products and accelerate growth.
What's next for Cryogenx?
The substantial enterprise-level financing Cryogenx has garnered signals a pivotal phase of scaling and market penetration. This strategic investment is expected to fuel the expansion of their product line, enhance manufacturing capabilities, and broaden their reach into critical sectors facing significant heat-related health challenges. Future growth will likely involve solidifying partnerships with industrial clients and government agencies, further establishing the CGX1 device as an essential safety tool in an increasingly warming world. The company's trajectory suggests a strong focus on innovation and market leadership in emergency cooling solutions.
See full Cryogenx company page
